BioCentury
ARTICLE | Management Tracks

Garijo picked to succeed Oschmann at Merck KGaA; plus BioShin, Abeona, Rubius, Nimbus, Vizgen  

September 29, 2020 12:07 AM UTC

Stefan Oschmann will hand the titles of executive board chair and CEO of Merck KGaA (Xetra:MRK) to Belén Garijo on May 1, 2021. Garijo is the German company’s vice chair and deputy CEO, as well as its CEO of healthcare. Oschmann will leave the company after 10 years on the executive board, five of them as chairman and CEO. 

Joining Merck’s executive team next year will be Peter Guenter and Matthias Heinzel as its CEOs of healthcare and life science, respectively. Guenter, who will be located in Darmstadt, Germany, has been CEO of Almirall S.A. (Madrid:ALM) since 2017. Heinzel will be based in Darmstadt and Burlington, Mass., beginning April 1 at the latest; he is president of nutrition and biosciences at DuPont...